|
1
|
Pérez-Tomás R: Multidrug resistance:
Retrospect and prospects in anti-cancer drug treatment. Curr Med
Chem. 13:1859–1876. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eytan GD: Mechanism of multidrug
resistance in relation to passive membrane permeation. Biomed
Pharmacother. 59:90–97. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Johnson WW: P-glycoprotein-mediated efflux
as a major factor in the variance of absorption and distribution of
drugs: Modulation of chemotherapy resistance. Methods Find Exp Clin
Pharmacol. 24:501–514. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fojo T and Bates S: Strategies for
reversing drug resistance. Oncogene. 22:7512–7523. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dean M, Rzhetsky A and Allikmets R: The
human ATP-binding cassette (ABC) transporter superfamily. Genome
Res. 11:1156–1166. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mi YJ, Liang YJ, Huang HB, Zhao HY, Wu CP,
Wang F, Tao LY, Zhang CZ, Dai CL, Tiwari AK, et al: Apatinib
(YN968D1) reverses multidrug resistance by inhibiting the efflux
function of multiple ATP-binding cassette transporters. Cancer Res.
70:7981–7991. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tong XZ, Wang F, Liang S, Zhang X, He JH,
Chen XG, Liang YJ, Mi YJ, To KK and Fu LW: Apatinib (YN968D1)
enhances the efficacy of conventional chemotherapeutical drugs in
side population cells and ABCB1-overexpressing leukemia cells.
Biochem Pharmacol. 83:586–597. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang F, Mi YJ, Chen XG, Wu XP, Liu Z, Chen
SP, Liang YJ, Cheng C, To KK and Fu LW: Axitinib targeted cancer
stemlike cells to enhance efficacy of chemotherapeutic drugs via
inhibiting the drug transport function of ABCG2. Mol Med.
18:887–898. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou WJ, Zhang X, Cheng C, Wang F, Wang
XK, Liang YJ, To KK, Zhou W, Huang HB and Fu LW: Crizotinib
(PF-02341066) reverses multidrug resistance in cancer cells by
inhibiting the function of P-glycoprotein. Br J Pharmacol.
166:1669–1683. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zheng LS, Wang F, Li YH, Zhang X, Chen LM,
Liang YJ, Dai CL, Yan YY, Tao LY, Mi YJ, et al: Vandetanib
(Zactima, ZD6474) antagonizes ABCC1- and ABCG2-mediated multidrug
resistance by inhibition of their transport function. PLoS One.
4:e51722009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gao JM, Wu WJ, Zhang JW and Konishi Y: The
dihydro-beta-agarofuran sesquiterpenoids. Nat Prod Rep.
24:1153–1189. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brinker AM, Ma J, Lipsky PE and Raskin I:
Medicinal chemistry and pharmacology of genus Tripterygium
(Celastraceae). Phytochemistry. 68:732–766. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Salminen A, Lehtonen M, Suuronen T,
Kaarniranta K and Huuskonen J: Terpenoids: Natural inhibitors of
NF-kappaB signaling with anti-inflammatory and anticancer
potential. Cell Mol Life Sci. 65:2979–2999. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu CC, Chan ML, Chen WY, Tsai CY, Chang FR
and Wu YC: Pristimerin induces caspase-dependent apoptosis in
MDA-MB-231 cells via direct effects on mitochondria. Mol Cancer
Ther. 4:1277–1285. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nagase M, Oto J, Sugiyama S, Yube K,
Takaishi Y and Sakato N: Apoptosis induction in HL-60 cells and
inhibition of topoisomerase II by triterpene celastrol. Biosci
Biotechnol Biochem. 67:1883–1887. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo Y, Zhang W, Yan YY, Ma CG, Wang X,
Wang C and Zhao JL: Triterpenoid pristimerin induced HepG2 cells
apoptosis through ROS-mediated mitochondrial dysfunction. J BUON.
18:477–485. 2013.PubMed/NCBI
|
|
17
|
Robey RW, Honjo Y, Morisaki K, Nadjem TA,
Runge S, Risbood M, Poruchynsky MS and Bates SE: Mutations at
amino-acid 482 in the ABCG2 gene affect substrate and antagonist
specificity. Br J Cancer. 89:1971–1978. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu QL, Wu XP, Liang YJ, Chen LM, Ding Y
and Fu LW: P-glycoprotein is not involved in pathway of
anti-Fas/Fas-induced apoptosis in KBv200 cells. World J
Gastroenterol. 11:3544–3548. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao XQ, Xie JD, Chen XG, Sim HM, Zhang X,
Liang YJ, Singh S, Talele TT, Sun Y, Ambudkar SV, et al: Neratinib
reverses ATP-binding cassette B1-mediated chemotherapeutic drug
resistance in vitro, in vivo, and ex vivo. Mol Pharmacol. 82:47–58.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yan YY, Zheng LS, Zhang X, Chen LK, Singh
S, Wang F, Zhang JY, Liang YJ, Dai CL, Gu LQ, et al: Blockade of
Her2/neu binding to Hsp90 by emodin azide methyl anthraquinone
derivative induces proteasomal degradation of Her2/neu. Mol Pharm.
8:1687–1697. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dai CL, Tiwari AK, Wu CP, Su XD, Wang SR,
Liu DG, Ashby CR Jr, Huang Y, Robey RW, Liang YJ, et al: Lapatinib
(Tykerb, GW572016) reverses multidrug resistance in cancer cells by
inhibiting the activity of ATP-binding cassette subfamily B member
1 and G member 2. Cancer Res. 68:7905–7914. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yan Y, Su X, Liang Y, Zhang J, Shi C, Lu
Y, Gu L and Fu L: Emodin azide methyl anthraquinone derivative
triggers mitochondrial-dependent cell apoptosis involving in
caspase-8-mediated Bid cleavage. Mol Cancer Ther. 7:1688–1697.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Johnstone RW, Cretney E and Smyth MJ:
P-glycoprotein protects leukemia cells against caspase-dependent,
but not caspase-independent, cell death. Blood. 93:1075–1085.
1999.PubMed/NCBI
|
|
25
|
Johnstone RW, Ruefli AA, Tainton KM and
Smyth MJ: A role for P-glycoprotein in regulating cell death. Leuk
Lymphoma. 38:1–11. 2000.PubMed/NCBI
|
|
26
|
Ruefli AA, Smyth MJ and Johnstone RW: HMBA
induces activation of a caspase-independent cell death pathway to
overcome P-glycoprotein-mediated multidrug resistance. Blood.
95:2378–2385. 2000.PubMed/NCBI
|
